Physician profile
Navid Mostofi
NPI 1912124983
$1,243.23
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,195 · 2020: $48.52.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $238.51 | 2019-2020 | |
| Genzyme Corporation | $146.33 | 2019-2020 | |
| Biogen, INC. | $111.68 | 2019 | |
| Amgen INC. | $107.61 | 2019 | |
| Avanir Pharmaceuticals, INC. | $96.04 | 2019 | |
| Emd Serono, INC. | $83.17 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $72.79 | 2019 | |
| Supernus Pharmaceuticals, INC. | $56.83 | 2019-2020 | |
| Allergan, INC. | $51.90 | 2019 | |
| Sunovion Pharmaceuticals INC. | $51.59 | 2019 | |
| Lilly USA, LLC | $51.09 | 2019 | |
| Amneal Pharmaceuticals LLC | $42.35 | 2019 | |
| Alexion Pharmaceuticals, INC. | $38.09 | 2019 | |
| Adamas Pharmaceuticals, INC. | $37.12 | 2019 | |
| Catalyst Pharmaceuticals, INC. | $19.60 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acorda Therapeutics, INC | $19.47 | 2019 | |
| Jazz Pharmaceuticals INC. | $19.06 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Navid Mostofi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.